In this connection, the potential function of YTHDF1 in CRC stemness is supported by its positive correlation with stemness markers CD133 and LGR5 across multiple CRC patient cohorts, as well as with LGR5 stem cell expression signatures and chemotherapy nonresponders. This evidence concerns the gene PROM1 and colorectal carcinoma.